Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Rhythm Pharmaceuticals: Building A Defensive MC4R Franchise (NASDAQ:RYTM) - Seeking Alpha

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

LEO Pharma buys worldwide dersimelagon rights for up to $435 million - Reuters

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals Phase 3 LUCIDITY Trial Meets Primary Endpoint for Avexitide - Yahoo Finance

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

New Windsor Planning Board gives Garonit green light for major pharmaceutical facility - Mid Hudson News

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Why Amylyx Pharmaceuticals Stock Skyrocketed Today - The Motley Fool

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Milestone Pharmaceuticals: Reiterating Sell As The Losses Compound (NASDAQ:MIST) - Seeking Alpha

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Why Amylyx Pharmaceuticals Stock Skyrocketed Today - Yahoo Finance

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu - Fierce Pharma

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Amylyx GLP-1 inhibitor halves blood sugar crashes in ph. 3 win - Fierce Biotech

news.google.com · 19 Aug 2026

Google News – Biopharma External News

Accelerating India’s Biopharma Transformation: Building Talent, Technology and an Innovation Ecosystem - eHealth Magazine

news.google.com · 19 Aug 2026

Google News – Biopharma External News

AstraZeneca, GSK intensify China ties with Sino Biopharm deals - BioPharma Dive

news.google.com · 19 Aug 2026

Google News – Biopharma External News

101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com

news.google.com · 19 Aug 2026

Google News – Biopharma External News

Thermo Fisher Scientific Brings Global Biopharma Expertise to India, Showcases Next-Generation Technologies and Strengthens Local Innovation Ecosystem - eHealth Magazine

news.google.com · 19 Aug 2026

Google News – Biopharma External News

Cue Biopharma VP Michael Meluzio disposes of $169,323 in stock By Investing.com - Investing.com Canada

news.google.com · 19 Aug 2026

Google News – Biopharma External News

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP - The Manila Times

news.google.com · 19 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Rhythm Pharmaceuticals: Building A Defensive MC4R Franchise (NASDAQ:RYTM) - Seeking Alpha

LEO Pharma buys worldwide dersimelagon rights for up to $435 million - Reuters

Amylyx Pharmaceuticals Phase 3 LUCIDITY Trial Meets Primary Endpoint for Avexitide - Yahoo Finance

New Windsor Planning Board gives Garonit green light for major pharmaceutical facility - Mid Hudson News

Why Amylyx Pharmaceuticals Stock Skyrocketed Today - The Motley Fool

Milestone Pharmaceuticals: Reiterating Sell As The Losses Compound (NASDAQ:MIST) - Seeking Alpha

Why Amylyx Pharmaceuticals Stock Skyrocketed Today - Yahoo Finance

EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu - Fierce Pharma

Amylyx GLP-1 inhibitor halves blood sugar crashes in ph. 3 win - Fierce Biotech

Accelerating India’s Biopharma Transformation: Building Talent, Technology and an Innovation Ecosystem - eHealth Magazine

AstraZeneca, GSK intensify China ties with Sino Biopharm deals - BioPharma Dive

101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com

Thermo Fisher Scientific Brings Global Biopharma Expertise to India, Showcases Next-Generation Technologies and Strengthens Local Innovation Ecosystem - eHealth Magazine

Cue Biopharma VP Michael Meluzio disposes of $169,323 in stock By Investing.com - Investing.com Canada

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP - The Manila Times